UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD
WKN 986327 | ISIN LU0069152568 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | CH0113817123 | Bellevue Biotech DT CHF | +4,67 % | +18,17 % | 0,12 |
|
| 2 | LU1269736838 | Candriam Equities L Biotech.R EUR Acc | +2,75 % | +18,06 % | 0,01 |
|
| 3 | LU1120766032 | Candriam Equities L Biotech.I EUR Acc | +2,56 % | +17,81 % | 0,00 |
|
| 4 | LU2026682919 | Candriam Equities L Biotech.V2 USD Acc | +2,16 % | +17,71 % | -0,02 |
|
| 5 | LU0942225912 | Candriam Equities L Biotech.R USD Acc | +1,93 % | +17,69 % | -0,03 |
|
| 40 | LU0069152568 | UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD | -3,21 % | +19,13 % | -0,30 |
|
| 73 | LU0774687577 | Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP | -10,03 % | +17,82 % | -0,70 |
|
| 74 | LU1803069274 | F.Biotechnology Dis.Fd.A-H1 EUR H | -11,03 % | +18,93 % | -0,72 |
|
| 75 | LU0959058974 | Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 | -13,38 % | +18,99 % | -0,84 |
|
| 76 | DE000A3DCA95 | BIT Biotech Opportunities S | -30,52 % | +29,53 % | -1,12 |
|
| 77 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -30,71 % | +29,52 % | -1,13 |
|